Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers new substrate specificity towards flavonoids

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-081x|36|8|552-563

ISSN： 0142-2782

Source： Biopharmaceutics And Drug Disposition, Vol.36, Iss.8, 2015-11, pp. : 552-563

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Substrate Specificity, Regulation, and Polymorphism of Human Cytochrome P450 2B6

By  

Current Drug Metabolism, Vol. 10, Iss. 7, 2009-09 ,pp. : 730-753

Bentham Science Publishers

Access to resources Recommend Favorite

Substrate Specificity, Inhibitors and Regulation of Human Cytochrome P450 2D6 and Implications in Drug Development

By  

Current Medicinal Chemistry, Vol. 16, Iss. 21, 2009-07 ,pp. : 2661-2805

Bentham Science Publishers

Access to resources Recommend Favorite

CYP2B6: New Insights into a Historically Overlooked Cytochrome P450 Isozyme

By  

Current Drug Metabolism, Vol. 9, Iss. 7, 2008-09 ,pp. : 598-610

Bentham Science Publishers

Access to resources Recommend Favorite

Common and Distinct Interactions of Chemical Inhibitors with Cytochrome P450 CYP1A2, CYP2A6 and CYP2B6 Enzymes

By  

Drug Metabolism Letters, Vol. 10, Iss. 1, 2016-03 ,pp. : 56-64

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic Polymorphism in Cytochrome P450 2D6 (CYP2D6): Population Distribution of CYP2D6 Activity

By Neafsey Patricia  

Journal of Toxicology and Environmental Health Part B: Critical Reviews, Vol. 12, Iss. 5-6, 2009-05 ,pp. : 334-361

Taylor & Francis Ltd

Access to resources Recommend Favorite